iBstone AuraLink vs Resound Vivia 9 60S microRIE

The iBstone AuraLink is a mid-priced OTC hearing aid released in 2024, earning a B grade with a SoundScore of 3.6/5 in our lab testing. At $649, it ranks #33 of 65 OTC hearing aids tested, placing it in the top 49% of its category. This behind-the-ear device demonstrates a distinctive performance profile with notable strengths in specific areas. Music streaming stands out as a clear highlight, scoring 3.6/5—a solid result that lands 1.68 points above the OTC category average. Feedback handling is excellent at 5.0/5, exceeding the already-high category average by 0.46 points. Own-voice comfort scores 2.7/5, slightly above the category average but only mixed in absolute terms. The AuraLink's limitations appear in speech clarity metrics. Speech in quiet scores 2.3/5, falling 0.47 points below the category average—a mixed result that may affect conversational understanding in calm environments. Speech in noise presents a more significant challenge at 1.0/5, which is 0.48 points below the category average and low in absolute terms. This hearing aid may appeal most to users who prioritize music listening and phone streaming over speech clarity in challenging environments. However, budget-conscious shoppers should note that alternatives like the iHear MatriX offer higher scores at lower prices. The AuraLink's strength in feedback stability and streaming audio quality represents a specific value proposition for users whose priorities align with these capabilities.

The ReSound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In our lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #29 of 39 prescription hearing aids tested. This device shows a mixed performance profile. Its standout strength is own-voice comfort, scoring 3.4/5—a solid result that sits 0.70 points above the category average. Speech clarity in quiet environments also performs at category average with a score of 3.4/5. Feedback handling is strong in absolute terms at 4.2/5, though this falls 0.52 points below the category average, reflecting the high bar set by competing prescription devices. The Vivia 9's most notable weakness is speech understanding in noisy environments, where it scored just 1.1/5—a low result that trails the category average by 0.96 points. Music streaming performance is mixed at 2.6/5, sitting slightly below average. These limitations are worth considering given the premium price positioning. For listeners who prioritize comfortable own-voice perception and primarily encounter quieter listening situations, the Vivia 9 may be suitable. However, those frequently in challenging noise environments should note that several alternatives in this price range—including the Phonak Sphere Infinio and Oticon Intent—deliver stronger overall performance in our testing. Budget-conscious shoppers may also find comparable sound quality at lower price points with options like the Jabra Enhance Pro 20 at Costco.